tm logo
BIOISIM
Live/Registered
REGISTERED

on 13 Jun 2023

Last Applicant/ Owned by

1 Sansome Street, Suite 3500

San Francisco

CA

94104

Serial Number

97032587 filed on 17th Sep 2021

Registration Number

7078084 registered on 13th Jun 2023

in the Principal Register

Correspondent Address

Norm J. Rich

FOLEY & LARDNER LLP

6TH FLOOR

3000 K STREET, N.W.

WASHINGTON DC 20007-5109

Filing Basis

1. use application currently

Disclaimer

"BIOSIM"

BIOISIM

"BIOSIM" Software as a service (SAAS) services featuring software for modeling and the conducting of simulations of properties of drugs or chemicals including absorption, release rate, bioavailability, pharmacokinetics and pharmacodynamics, safety, toxicology, and efficacy profiles, routes of administration, and dose optimization; Software as a service (SAAS) services featuring software that allo Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Software as a service (SAAS) services featuring software for modeling and the conducting of simulations of properties of drugs or chemicals including absorption, release rate, bioavailability, pharmacokinetics and pharmacodynamics, safety, toxicology, and efficacy profiles, routes of administration, and dose optimization; Software as a service (SAAS) services featuring software that allows for the prediction of drug-to-drug interactions; Software as a service (SAAS) services featuring software for the prediction of drug effects on animals and virtual patient populations; Software as a service (SAAS) services featuring software which allows researchers to adjust pharmacodynamic models to observed data and to then use the resulting fitted models to predict pharmacodynamic changes due to changes in routes of administration, dose, dosage form, and dosing regimen of a drug or chemical; Software as a service (SAAS) services featuring software which allow for the prediction of absorption and systemic distribution/elimination for large molecules; Software as a service (SAAS) services featuring software that incorporates artificial intelligence and machine learning to predict the clinical efficacy of new drugs before human trials and accelerate pharmaceutical drug development and FDA approval


First Use Date in General

01st May 2018

First Use Date in Commerce

14th Aug 2018

Specimens


BIOISIM specimenBIOISIM specimenBIOISIM specimenBIOISIM specimenBIOISIM specimenBIOISIM specimen

Mark Details


Serial Number

No 97032587

Mark Type

No Service Mark

Attorney Docket Number

No 117407-0105

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
13th Jun 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
13th Jun 2023REGISTERED-PRINCIPAL REGISTER
28th Mar 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28th Mar 2023PUBLISHED FOR OPPOSITION
08th Mar 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21st Feb 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
21st Feb 2023EXAMINERS AMENDMENT E-MAILED
21st Feb 2023EXAMINER'S AMENDMENT ENTERED
21st Feb 2023APPROVED FOR PUB - PRINCIPAL REGISTER
21st Feb 2023EXAMINERS AMENDMENT -WRITTEN